blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2264174

EP2264174 - Protein similar to neuroendocrine-specific protein, and encoding CDNA [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.03.2016
Database last updated on 25.09.2024
Most recent event   Tooltip18.03.2016Application deemed to be withdrawnpublished on 20.04.2016  [2016/16]
Applicant(s)For all designated states
SmithKline Beecham Limited
980 Great West Road Brentford
Middlesex TW8 9GS / GB
[2010/51]
Inventor(s)01 / Michalovich, David
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM17 5AW / GB
02 / Prinjha, Rabinder Kumar
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
 [2010/51]
Representative(s)Chiappinelli, Susan Ann, et al
GSK
Legal & Compliance - Global Patents
79 New Oxford Street
London WC1A 1DG / GB
[N/P]
Former [2010/51]Sayce, Alastair George, et al
GlaxoSmithKline Corporate Intellectual Property (CN925.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date10156270.021.07.1999
[2010/51]
Priority number, dateGB1998001602422.07.1998         Original published format: GB 9816024
GB1999001689819.07.1999         Original published format: GB 9916898
[2010/51]
Previously filed application, dateWO1999GB0236021.07.1999
[2010/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2264174
Date:22.12.2010
Language:EN
[2010/51]
Type: A3 Search report 
No.:EP2264174
Date:07.03.2012
Language:EN
[2012/10]
Search report(s)(Supplementary) European search report - dispatched on:EP02.02.2012
ClassificationIPC:C12N15/12, C07K14/47, C07K16/18, G01N33/68, C12Q1/68
[2010/51]
CPC:
C07K14/47 (EP,US); C12N9/2497 (US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2010/51]
TitleGerman:Protein, das mit einem Neuroendokrinspezifischen Protein änhelt, und dafür kodierende cDNS[2010/51]
English:Protein similar to neuroendocrine-specific protein, and encoding CDNA[2010/51]
French:Protéine semblable à la protéine spécifique des cellules neuroendocriniennes et ADNc codant[2010/51]
Examination procedure11.03.2010Examination requested  [2010/51]
17.12.2012Amendment by applicant (claims and/or description)
29.04.2013Despatch of a communication from the examining division (Time limit: M06)
04.11.2013Reply to a communication from the examining division
06.06.2014Despatch of a communication from the examining division (Time limit: M06)
20.03.2015Reply to a communication from the examining division
02.07.2015Despatch of a communication from the examining division (Time limit: M04)
13.11.2015Application deemed to be withdrawn, date of legal effect  [2016/16]
09.12.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/16]
Parent application(s)   TooltipEP99934913.7  / EP1098972
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19990934913) is  04.05.2007
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.03.2015Request for further processing filed
20.03.2015Full payment received (date of receipt of payment)
Request granted
01.04.2015Decision despatched
The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
17.12.2012Request for further processing filed
17.12.2012Full payment received (date of receipt of payment)
Request granted
04.01.2013Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
17.12.2012Request for further processing filed
17.12.2012Full payment received (date of receipt of payment)
Request granted
04.01.2013Decision despatched
Fees paidRenewal fee
11.03.2010Renewal fee patent year 03
11.03.2010Renewal fee patent year 04
11.03.2010Renewal fee patent year 05
11.03.2010Renewal fee patent year 06
11.03.2010Renewal fee patent year 07
11.03.2010Renewal fee patent year 08
11.03.2010Renewal fee patent year 09
11.03.2010Renewal fee patent year 10
11.03.2010Renewal fee patent year 11
08.07.2010Renewal fee patent year 12
16.07.2011Renewal fee patent year 13
10.07.2012Renewal fee patent year 14
08.07.2013Renewal fee patent year 15
08.07.2014Renewal fee patent year 16
09.07.2015Renewal fee patent year 17
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9806841  (INCYTE PHARMA INC [US], et al) [X] 1-12 * abstract * * page 2, line 43 - page 3, line 20; figures 2,6 * * page 7, line 41 - page 9, line 14 * * page 16, lines 23-30 * * page 18, line 33 - page 19, line 13 * * page 35, line 33 - page 36, line 7 * * 99% identity between Seq.ID:1 nt.108-674 and Seq.ID:1 of current application nt.3013-3579 99% identity between Seq.ID:2 and Seq.ID:2 of current application aa.1005-1192; page 38 - page 39 * * page 46; claims 1-14 *;
 [X]WO9817687  (GENETICS INST [US]) [X] 1-12 * page 6, line 32 - page 8, line 19 * * page 23, line 12 - page 24, line 14 * * page 34, lines 16-22 * * page 54, line 17 - page 55, line 5 * * 99% identity between Seq.ID:8 nt.1-1714 and Seq.ID:1 of current application nt.1535-3246 99% identity between Seq.ID:9 and Seq.ID:2 of current application aa.546-1192; page 73 - page 77 * * page 101 - page 102; claims 20-22 *;
 [XP]WO9845435  (GENETICS INST [US]) [XP] 1-12 * page 56, lines 28-34 * * page 64, lines 10-14 * * page 77, line 15 - page 78, line 2 * * page 83, lines 16-30 * * 100% identity between Seq.ID:1008 and Seq.ID:1 of current application nt.1540-1971; page 428 *;
 [XP]WO9845437  (GENETICS INST [US]) [XP] 1-12 * page 56, lines 28-34 * * page 64, lines 10-14 * * page 77, line 15 - page 78, line 2 * * page 83, lines 16-30 * * 99% identity between Seq.ID:366 and Seq.ID:1 of current application nt.862-1184; page 213 *;
 [XP]WO9856804  (HUMAN GENOME SCIENCES INC [US], et al) [XP] 1-12 * abstract * * page 62, lines 1-32 * * Gene No.69; page 82 * * page 85, line 29 - page 87, line 11 * * page 95, line 34 - page 96, line 32 * * page 111, line 6 - page 112, line 16 * * 99% identity between Seq.ID:79 nt.248-814 and Seq.ID:1 of current application nt.3013-3579; page 235 - page 236 * * 100% identity between Seq.ID:179 and Seq.ID:2 of current application aa.1019-1192; page 303 * * 99% identity between Seq.ID:301 and Seq.ID:2 of current application aa.1002-1192; page 354 - page 355 * * page 370 - page 373; claim - *;
 [XP]WO9906548  (GENSET SA [FR], et al) [XP] 1-12 * page 6, line 23 - page 7, line 27 * * page 78, line 6 - page 79, line 2; example 39 * * page 84, line 1 - page 85, line 24; example 43 * * 99% identity between Seq.ID:137 nt.165-404 and Seq.ID:1 of current application nt.3013-3252 97% identity between Seq.ID:391 and Seq.ID:2 of current application aa.1002-1084; page 144 - page 148; claim - *;
 [XP]WO9931236  (GENSET SA [FR], et al) [XP] 1-12 * abstract * * page 5, lines 21-34 * * page 32, lines 3-8 * * page 62, line 21 - page 63, line 5; example 38 * * page 64, line 11 - page 67, line 27; examples 39,40 * * 99% identity between Seq.ID:51 nt.68-634 and Seq.ID:1 of current application nt.3013-3579 98% identity between Seq.ID:152 and Seq.ID:2 of current application aa.1002-1192; page 137 - page 138; claim - *;
 [XP]WO9933979  (CHIRON CORP [US]) [XP] 1-12 * 99% identity between Seq.ID:5 nt.687-1253 and Seq.ID:1 of current application nt.3013-3579 100% identity between Seq.ID:6 aa.1-185 and Seq.ID:2 of current application aa.1-185; page 23, lines 5-15 * * page 33, lines 8-15 * * page 44, lines 4-9 * * page 49, line 24 - page 50, line 10 * * page 59 - page 67; claim - *;
 [X]  - EMBL NUCLEOTIDE SEQU, (19000101), Database accession no. AA307342, XP002120596 [X] 1-9,11,12 * the whole document *
 [XP]  - MORRIS N.J. ET AL., "Cloning and characterization of a 22 kDa protein from rat adipocytes: a new member of the reticulon family", BIOCHIMICA ET BIOPHYSICA ACTA, (19990506), vol. 1450, no. 1, pages 68 - 76, XP002121224 [XP] 1-9,11,12 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0167-4889(99)00033-6
 [XP]  - NAGASE T. ET AL., "Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro", DNA RESEARCH, (199812), vol. 5, no. 5, ISSN 1340-2838, pages 355 - 364 64, XP002111974 [XP] 1-5,11,12 * the whole document *

DOI:   http://dx.doi.org/10.1093/dnares/5.6.355
Examination   - PRINJHA R ET AL, "Inhibitor of neurite outgrowth in humans.", NATURE 27 JAN 2000, (20000127), vol. 403, no. 6768, ISSN 0028-0836, pages 383 - 384, XP055060480

DOI:   http://dx.doi.org/10.1038/35000287
    - GRANDPRE TADZIA ET AL, "Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein", NATURE (LONDON), (20000127), vol. 403, no. 6768, ISSN 0028-0836, pages 439 - 444, XP001010115

DOI:   http://dx.doi.org/10.1038/35000226
    - SPILLMANN ET AL, "Identification and Characterization of a Bovine Neurite Growth Inhibitor (bNI-220)", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19980724), vol. 273, no. 30, doi:10.1074/JBC.273.30.19283, ISSN 0021-9258, pages 19283 - 19293, XP002162896

DOI:   http://dx.doi.org/10.1074/jbc.273.30.19283
    - CHEN M S ET AL, "MOLECULAR CLONING OF A GENE FOR A PUTATIVE INHIBITOR TO CNS REGENERATION", ABSTRACTS OF THE ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, SOCIETY FOR NEUROSCIENCE, WASHINGTON, DC, US, (19970101), vol. 23, no. 1/02, ISSN 0190-5295, page 1723+AN675.16, XP001070928
by applicantEP0232262
 US4946778
    - J. HENS ET AL., CELL TISSUE RES., (1998), vol. 292, pages 229 - 237
    - GEISLER ET AL., MAMM. GENOME, (1998), vol. 9, pages 164 - 173
    - SPILLMANN ET AL., J. BIOL. CHEM., (1998), vol. 273, pages 15487 - 15493
    - SENDEN ET AL., HISTOCHEM. CELL BIOL., (1997), vol. 108, pages 155 - 165
    - ROEBROEK ET AL., J. BIOL. CHEM., (1993), vol. 268, pages 13439 - 13447
    - ADAMS, M.D. ET AL., NATURE, (1995), vol. 377, page 3
    - GENTZET, PROC NATL ACAD SCI USA, (1989), vol. 86, pages 821 - 824
    - FROHMAN ET AL., PROC NAT ACAD SCI USA, (1988), vol. 85, pages 8998 - 9002
    - COTTONET, PROC NATL ACAD SCI USA, (1985), vol. 85, pages 4397 - 4401
    - M.CHEE ET AL., SCIENCE, (1996), vol. 274, pages 610 - 613
    - WALTER, M.; SPILLETT, D.; THOMAS, P.; WEISSENBACH, J.; GOODFELLOW, P., "A method for constructing radiation hybrid maps of whole genomes", NATURE GENETICS, (1994), vol. 7, pages 22 - 28
    - GYAPAY G; SCHMITT K; FIZAMES C; JONES H; VEGA-CZARNY N; SPILLETT D; MUSELET D; PRUD'HOMME JF; DIB C; AUFFRAY C, "A radiation hybrid map of the human genome", HUM MOL GENET, (199603), vol. 5, no. 3, pages 339 - 46
    - SCHENAET, SCIENCE, (1995), vol. 270, pages 467 - 470
    - SHALON ET AL., GENOME RES, (1996), vol. 6, pages 639 - 645
    - KOHLER, G.; MILSTEIN, C., NATURE, (1975), vol. 256, pages 495 - 497
    - KOZBOR ET AL., IMMUNOLOGY TODAY, (1983), vol. 4, page 72
    - SCHULLEK ET AL., ANAL BIOCHEM., (1997), vol. 246, pages 20 - 29
    - D. BENNETT ET AL., J MOL RECOGNITION, (1995), vol. 8, pages 52 - 58
    - K. JOHANSON ET AL., J BIOL CHEM, (1995), vol. 270, no. 16, pages 9459 - 9471
    - SEIFTER ET AL., "Analysis for protein modifications and nonprotein cofactors", METH ENZYMOL, (1990), vol. 182, pages 626 - 646
    - RATTAN ET AL., "Protein Synthesis: Post-translational Modifications and Aging", ANN NY ACAD SCI, (1992), vol. 663, pages 48 - 62
    - DEVEREUX J ET AL., NUCLEIC ACIDS RES, (1984), vol. 12, pages 387 - 395
    - SMITH; WATERMAN, J MOL BIOL, (1981), vol. 147, pages 195 - 197
    - ADVANCES IN APPLIED MATHEMATICS, (1981), vol. 2, pages 482 - 489
    - NEDDLEMAN; WUNSCH, J MOL BIOL, (1970), vol. 48, pages 443 - 453
    - ALTSCHUL S F ET AL., J MOL BIOL, (1990), vol. 215, pages 403 - 410
    - ALTSCHUL S F ET AL., NUCLEIC ACIDS RES., (1997), vol. 25, pages 389 - 3402
    - PEARSON W R, METHODS IN ENZYMOLOGY, (1990), vol. 183, pages 63 - 99
    - PEARSON W R; LIPMAN D J, PROC NAT ACAD SCI USA, (1988), vol. 85, pages 2444 - 2448
    - HENIKOFF S; HENIKOFF J G, PROC. NAT. ACAD SCI. USA, (1992), vol. 89, pages 10915 - 10919
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.